258 related articles for article (PubMed ID: 37038186)
21. Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity.
Voskens CJ; Watanabe R; Rollins S; Campana D; Hasumi K; Mann DL
J Exp Clin Cancer Res; 2010 Oct; 29(1):134. PubMed ID: 20937115
[TBL] [Abstract][Full Text] [Related]
22. Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D.
Gröschel C; Hübscher D; Nolte J; Monecke S; Sasse A; Elsner L; Paulus W; Trenkwalder C; Polić B; Mansouri A; Guan K; Dressel R
Front Immunol; 2017; 8():870. PubMed ID: 28890717
[TBL] [Abstract][Full Text] [Related]
23. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
24. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
[TBL] [Abstract][Full Text] [Related]
25. Identification and functional analysis of ligands for natural killer cell activating receptors in colon carcinoma.
Zhang Z; Su T; He L; Wang H; Ji G; Liu X; Zhang Y; Dong G
Tohoku J Exp Med; 2012 Jan; 226(1):59-68. PubMed ID: 22189020
[TBL] [Abstract][Full Text] [Related]
26. Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.
Carrega P; Pezzino G; Queirolo P; Bonaccorsi I; Falco M; Vita G; Pende D; Misefari A; Moretta A; Mingari MC; Moretta L; Ferlazzo G
PLoS One; 2009 Dec; 4(12):e8132. PubMed ID: 19997637
[TBL] [Abstract][Full Text] [Related]
27. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity.
Suzuki D; Flahou C; Yoshikawa N; Stirblyte I; Hayashi Y; Sawaguchi A; Akasaka M; Nakamura S; Higashi N; Xu H; Matsumoto T; Fujio K; Manz MG; Hotta A; Takizawa H; Eto K; Sugimoto N
Stem Cell Reports; 2020 Jan; 14(1):49-59. PubMed ID: 31883921
[TBL] [Abstract][Full Text] [Related]
28. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
[TBL] [Abstract][Full Text] [Related]
29. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.
Yu J; Heller G; Chewning J; Kim S; Yokoyama WM; Hsu KC
J Immunol; 2007 Nov; 179(9):5977-89. PubMed ID: 17947671
[TBL] [Abstract][Full Text] [Related]
30. Current status and future perspectives of HLA-edited induced pluripotent stem cells.
Koga K; Wang B; Kaneko S
Inflamm Regen; 2020; 40():23. PubMed ID: 33014207
[TBL] [Abstract][Full Text] [Related]
31. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
[TBL] [Abstract][Full Text] [Related]
32. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
33. Natural Killer Cell Inhibition by HLA-E Molecules on Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelial Cells.
Sugita S; Makabe K; Iwasaki Y; Fujii S; Takahashi M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1719-1731. PubMed ID: 29610856
[TBL] [Abstract][Full Text] [Related]
34. Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility.
Xu H; Wang B; Ono M; Kagita A; Fujii K; Sasakawa N; Ueda T; Gee P; Nishikawa M; Nomura M; Kitaoka F; Takahashi T; Okita K; Yoshida Y; Kaneko S; Hotta A
Cell Stem Cell; 2019 Apr; 24(4):566-578.e7. PubMed ID: 30853558
[TBL] [Abstract][Full Text] [Related]
35. Human NK cells: surface receptors, inhibitory checkpoints, and translational applications.
Sivori S; Vacca P; Del Zotto G; Munari E; Mingari MC; Moretta L
Cell Mol Immunol; 2019 May; 16(5):430-441. PubMed ID: 30778167
[TBL] [Abstract][Full Text] [Related]
36. HLA-based banking of induced pluripotent stem cells in Saudi Arabia.
Alowaysi M; Lehmann R; Al-Shehri M; Baadhaim M; Alzahrani H; Aboalola D; Zia A; Malibari D; Daghestani M; Alghamdi K; Haneef A; Jawdat D; Hakami F; Gomez-Cabrero D; Tegner J; Alsayegh K
Stem Cell Res Ther; 2023 Dec; 14(1):374. PubMed ID: 38111036
[TBL] [Abstract][Full Text] [Related]
37. An Ethanol Extract of
Kim A; Baek SJ; Shin S; Lee SY; Chung SK
Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
[TBL] [Abstract][Full Text] [Related]
38. Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark.
Nguyen V; Gao C; Hochman ML; Kravitz J; Chen EH; Friedman HI; Wenceslau CF; Chen D; Wang Y; Nelson JS; Jegga AG; Tan W
bioRxiv; 2023 Aug; ():. PubMed ID: 37662218
[TBL] [Abstract][Full Text] [Related]
39. Natural killer cell impairment in ovarian clear cell carcinoma.
Patrizi O; Rampinelli F; Coltrini D; Pesce S; Carlomagno S; Sivori S; Pascale A; Marcenaro E; Parolini S; Tabellini G
J Leukoc Biol; 2020 Oct; 108(4):1425-1434. PubMed ID: 32794325
[TBL] [Abstract][Full Text] [Related]
40. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
